Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge assists NAXS in connection with change of listing to NASDAQ OMX Stockholm
Mandate

Vinge assists NAXS in connection with change of listing to NASDAQ OMX Stockholm

June 01, 2010

NAXS Nordic Access Buyout Fund AB (publ) commenced operations in 2007 and is a company investing in buyout funds with a Nordic focus. The objective is to make the Nordic private equity market accessible to a broader range of investors, which are also offered liquidity through NAXS’s listed shares. The shares have been listed on NASDAQ OMX First North since May 2007 and the admittance to trading of the NAXS share on NASDAQ OMX Stockholm has now been approved by the NASDAQ OMX Stockholm’s Listing Committee. The first day of trading for NAXS’s shares on NASDAQ OMX Stockholm is expected to be Monday, 7 June 2010 and the last day of trading on NASDAQ OMX First North is expected to be Friday, 4 June 2010.

Vinge’s team has primarily consisted of Göran Nyström, Jesper Schönbeck and Emil Hedberg.

Related

Vinge advises Consolid Equity in connection with the establishment of Petra Group

 Vinge has advised Consolid Equity Investment AB ("Consolid Equity") on the acquisition of Ström & Gulliksson, one of the leading patent agencies in the Nordics. The acquisition forms part of the establishment of Petra Group, a European platform aimed at consolidating patent agencies across Europe to combine expertise and resources primarily within patents and trademarks. Consolid acts as a strategic partner in the new group.
July 08, 2026

Vinge has advised Scandic on new credit facilities with SEK 7.5 billion credit facilities

 Vinge has represented Scandic Hotels Group AB (publ) in connection with a facilities agreement for SEK 7,500,000,000 with a syndicate of banks, arranged by DNB Carnegie Investment Bank AB and Nordea Bank Abp, filial i Sverige.
July 08, 2026

Vinge has advised Vitamin Well and its majority shareholders Cinven, Bridgepoint and the founders on Vitamin Well's combination with EMPWR

 Vinge has advised Vitamin Well and its majority shareholders Cinven, the founders of Vitamin Well and Bridgepoint on Vitamin Well's acquisition of EMPWR Nutrition Group from majority seller Waterland Private Equity Investments.
July 03, 2026